MedPath

Efficacy of Pythagorean Self-Awareness Intervention for Major Depressive Disorder

Not Applicable
Completed
Conditions
Major Depressive Disorder
Interventions
Behavioral: Pythagorean Self-Awareness Intervention program
Registration Number
NCT04536714
Lead Sponsor
Evgenia E. Psarraki
Brief Summary

The present study explored the effects of the implementation of the Pythagorean Self Awarenes Intervention (PSAI) on patients diagnosed with major depressive disorder. The primary aim was to evaluate the effectiveness of PSAI compared to the usual care provided for adults with major depressive disorder with respect to the reduction of depressive symptoms. Secondary aims of this study included reduction of stress and anxiety, enhancement of healthy lifestyle and improvement of affect, sleep quality and cognitive functions of patients.

Detailed Description

Study design This randomized controlled trial was conducted at the Mental Health Center of Peristeri, department of the Psychiatric Hospital of Attica, Greece, from December 2018 to January 2020. The study protocol was approved by the School of Medicine, National and Kapodistrian University of Athens (Protocol n. 1718038002/30/07/2018) and the center's directorate and was consistent with the Declaration of Helsinki. All participants were enlisted in the study only after being fully informed by the researcher about the aims and procedures of the research and submitting written consent.

Procedures Patients eligible for the above mentioned criteria were randomized in two groups: the intervention group, receiving PSAI, and the control group, receiving the usual care provided by the center for patients with MDD, namely medical treatment and counselling. Randomization was conducted based on random numbers generated by an online random number generator (https://www.sealedenvelope.com/simple-randomiser/v1/lists). This study was non-blinded, as patients and researchers were aware of the group assignment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • major depressive disorder diagnosis conducted by a psychiatrist of the center according to the DSM-V criteria
  • residency in Attica
  • ability to speak and write fluently in the Greek language
Exclusion Criteria
  • antecedent psychotic or manic episode
  • current feeding or eating disorder, obsessive-compulsive disorder, self-harming behaviors or recent suicide attempt and current drug abuse or addiction
  • current treatment with Cognitive-Behavioral Therapy
  • denial to participate in the research

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupPythagorean Self-Awareness Intervention program34 participants. Received Pythagorean Self-Awareness program
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory-II2 months

self-report questionnaire

Secondary Outcome Measures
NameTimeMethod
Healthy Lifestyle and Personal Control Questionnaire2 months

self-report questionnaire

Brief International Assessment of Cognition for Multiple Sclerosis2 months

battery of three cognitive tests

Pittsburg Sleep Quality Index2 months

self-report questionnaire

Hair cortisol concentration2 months

Hair specimens from the posterior vertex of the scalp, three proximal to scalp cms

Salivary cortisol concentration2 months

saliva specimens,three measurements in 24 hours: two in the morning (on awakening and 40 minutes later) and one at night (at 8:00). CAR and diurnal slope of cortisol were also calculated

Depression-Anxiety-Stress Scale-212 months

self-report questionnaire

Positive and Negative Affect Schedule2 months

self-report questionnaire

Trial Locations

Locations (1)

Mental Health Center of Peristeri, department of the Psychiatric Hospital of Attica, Ploutonos 19

🇬🇷

Peristeri, Attica, Greece

© Copyright 2025. All Rights Reserved by MedPath